ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Similar documents
Mahindra & Mahindra Ltd.

Amber Enterprises India Ltd

Mahindra & Mahindra Ltd.

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

Bata India BUY. Performance Update. CMP Target Price `842. 1QFY2019 Result Update Footwear. Historical share price chart.

Hindustan Media Ventures

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Bata India BUY. Performance Update. CMP `1,008 Target Price `1,243. 2QFY2019 Result Update Footwear. Historical share price chart.

Procter & Gamble Hygiene & Health Care

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

KEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart.

KEI Industries BUY. Performance Update. Target Price. 3QFY2018 Result Update Cable. Historical share price chart. Key Financials

TV Today Network BUY. Performance Update. CMP Target Price `315 `385. 2QFY2017 Result Update Media. Historical share price chart.

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Mahindra & Mahindra Ltd.

LT Foods BUY. Performance Update. CMP Target Price `76 `128. 4QFY2018 Result Update Media

LT Foods BUY. Performance Update. CMP Target Price `92 `128. 3QFY2018 Result Update Media February 12, 2018

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,226 Target Price `3,466. 3QFY2017 Result Update Automobile. 3-year price chart

Ambuja Cements ACCUMULATE. Performance Highlights. CMP Target Price `207 `233. 3QCY2015 Result Update Cement. Quarterly results (Standalone)

ACC BUY. Performance Highlights. CMP `1,397 Target Price `1,630. 3QCY2015 Result Update Cement

Rallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

Transport Corporation of India

Century Plyboards Ltd

Rallis India NEUTRAL. Performance Highlights CMP. `242 Target Price - 4QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Matrimony.com Ltd BUY. Performance Update. Target Price `1,016. 4QFY2018 Result Update Cable. Historical share price chart.

Goodyear India BUY. Company Update. CMP Target Price `515 `631. Company Update Tyres. 3-year Daily Price Chart. Key Financials

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

Graphite India BUY. Performance Highlights. CMP Target Price `88 `109. 1QFY2012 Result Update Capital Goods

Rallis India NEUTRAL. Performance Highlights CMP. `215 Target Price - 3QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Blue Star Ltd BUY. Performance Update. CMP Target Price `754 `867. 4QFY2018 Result Update Cons. Durable. 3-year price chart.

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,718 Target Price `4,130. 1QFY2018 Result Update Automobile. 3-year price chart

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

Graphite India BUY. Performance Highlights CMP. `93 Target Price `124. 4QFY2012 Result Update Capital Goods. Investment Period 12 Months

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

Jindal Steel & Power BUY. CMP Target Price `200 `320. 1QFY2019 Result Update Steel & Power. Performance Update

Quick take. VIP Industries BUY. Travelling smart on the luggage track. CMP Target Price `153 ` year daily price chart

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 3QCY2017 Result Update Pharmaceutical. Investment Period 12 months

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 2QCY2017 Result Update Pharmaceutical. 3-year price chart.

Matrimony.com Ltd BUY. A complete package from matchmaking to wedding. Target Price. Initiating Coverage Internet Software & Services

Quick take. Ashok Leyland Ltd BUY. Scrappage policy to drive faster growth. Target Price. Investment Period 12 Months. 3-year price chart

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

Tata Steel NEUTRAL. Performance Highlights CMP. `226 Target Price - 2QFY2016 Result Update Steel. Investment Period - 3-year price chart

TV Today Network BUY. Go with the market leader. CMP Target Price `297 `363. Initiating Coverage Media. 3-year price chart

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

SpiceJet BUY. Performance Highlights CMP. `32 Target Price `43. 1QFY2013 Result Update Airlines. Investment Period 12 Months.

Sanofi India ACCUMULATE. Performance Highlights. CMP `4,410 Target Price `4,738. 1QCY2016 Result Update Pharmaceutical. 3-year price chart

Apollo Micro Systems Ltd

Sanofi India NEUTRAL. Performance Highlights. CMP `4,301 Target Price - 4QCY2016 Result Update Pharmaceutical. Investment Period - 3-year price chart

Future Supply Chain Solutions Ltd

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

ACC NEUTRAL. Performance Highlights. CMP `1,261 Target Price - 4QCY2012 Result Update Cement. Quarterly results (Standalone) Investment Period -

GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `7,622 Target Price `8,501. 1QFY2018 Result Update Automobile

MISHRA DHATU NIGAM Ltd.

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

Avenue Supermarts Limited

Varroc Engineering Ltd.

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

Newgen Software Technologies Ltd

Ambuja Cements NEUTRAL. Performance Highlights CMP. `184 Target Price - 2QCY2012 Result Update Cement. Quarterly results (Standalone)

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `495 Target Price - 4QFY2017 Result Update Pharmaceutical.

Ambuja Cements NEUTRAL. Performance Highlights CMP. `155 Target Price - 1QCY2011 Result Update Cement. Investment Period - Key financials (Standalone)

Bajaj Auto ACCUMULATE. Performance Highlights. CMP `2,815 Target Price `3,151. 1QFY2018 Result Update Automobile. 24 July 2017

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone)

Simplex Infrastructures

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

Axis Bank BUY. CMP Target Price `620 `750. Update Bank. Earnings to normalize with stabilizing credit costs. 3-year price chart.

Tata Consultancy Services (TCS)

ICICI Bank BUY. Performance Highlights. CMP Target Price `307 `411. 1QFY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

Quick take. Aditya Birla Nuvo BUY. Deep Value. Valuation Methodology. Exhibit 1: ABNL s Business Structure

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `5,715 Target Price `6,006. 2QFY2017 Result Update Automobile. 3-year price chart

Maruti Suzuki ACCUMULATE. Performance Highlights. CMP `5,797 Target Price `6,560. 3QFY2017 Result Update Automobile. 3-year price chart

Dr. Reddy s Laboratories

Navkar Corporation BUY. Performance Update. CMP Target Price `200 `265. 4QFY2016 Result Update Logistics. Historical share price chart

Navkar Corporation BUY. Performance Update. CMP Target Price `175 `265. 2QFY2017 Result Update Logistics. Historical share price chart.

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `440 Target Price. 3QFY2017 Result Update Pharmaceutical. Investment Period -

Colgate-Palmolive ACCUMULATE. Performance Highlights. 4QFY2010 Result Update I FMCG

Lupin BUY. Performance Highlights. CMP `1,493 Target Price `1,809. 2QFY2017 Result Update Pharmaceutical. 3-year price chart

Alembic BUY. Performance Highlights. Target Price. 1QFY2011 Result Update Pharmaceutical. Investment Period 12 months

GlaxoSmithKline Pharmaceuticals

Tech Mahindra ACCUMLATE. Performance Highlights `495 `526. CMP Target Price. 2QFY2018 Result Update IT

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `390 Target Price - 2QFY2017 Result Update Pharmaceutical. Investment Period -

Cairn India ACCUMULATE. Performance Highlights. CMP Target Price `338 `382. 2QFY2013 Result Update Oil & Gas. Quarterly highlights (Consolidated)

Lupin 1QFY2018 Result Update

Aster DM Healthcare Ltd

Transcription:

3QFY2017 Result Update FMCG January 30, 2017 ITC Performance Highlights Quarterly result (Standalone) (` cr) 3QFY17 3QFY16 % yoy 2QFY17 %qoq Revenue 9,248 8,867 4.3 9,661 (4.3) EBITDA 3,546 3,475 2.1 3,630 (2.3) OPM (%) 38.3 39.2 (84bp) 37.6 77bp PAT 2,647 2,504 5.7 2,500 5.9 Source: Company, Angel Research For 3QFY2017, ITC has reported below estimates numbers, both on the top-line and bottom-line fronts, on the back of lower Cigarettes volume growth due to demonetization of Indian currency. However, healthy growth was witnessed in other businesses like Hotels, Agri Business, etc. Key highlights: ITC s net sales for the quarter grew by 4.3% yoy to `9,248cr. In terms of segment wise performance (gross level), the Cigarettes business posted a growth of 2.2% yoy in sales to `8,288cr, aided by price hike (volume was flattish during the quarter). The other FMCG businesses posted a growth of 3.4% yoy in sales to `2,569cr. However, the Hotel division and Agri business posted a healthy revenue growth of ~7% and ~13% respectively, during the quarter. Overall, the company s OPM declined by 84bp yoy to 38.3% owing to an increase in raw material cost. Outlook and valuation: We expect ITC to report top-line and bottom-line CAGR of 9% and 12% respectively over FY2016-18E. At the current market price, the stock is trading at 26.9x its FY2018E EPS. We recommend an Accumulate rating on the stock with a Target Price of `284. Key financials (Standalone) Y/E March (` cr) FY2015 FY2016 FY2017E FY2018E Net Sales 36,507 36,583 38,935 43,170 % chg 9.8 0.2 6.4 10.9 Net Profit (Adj) 9,608 9,311 10,361 11,594 % chg 9.4 (3.1) 11.3 11.9 EBITDA (%) 36.9 37.5 38.3 39.2 EPS (`) 8.0 7.7 8.6 9.6 P/E (x) 32.4 33.5 30.1 26.9 P/BV (x) 10.2 9.5 8.1 7.1 RoE (%) 31.3 28.3 26.8 26.3 RoCE (%) 40.6 38.5 35.5 35.4 EV/Sales (x) 8.1 8.0 7.5 6.7 EV/EBITDA (x) 21.9 21.3 19.6 17.2 Source: Company, Angel Research; Note: CMP as of January 30, 2016 ACCUMULATE CMP `257 Target Price `284 Investment Period 12 Months Stock Info Sector FMCG Market Cap (` cr) 311,035 Net Debt (` cr) (19,376) Beta 0.8 52 Week High / Low 267/179 Avg. Daily Volume 916,990 Face Value (`) 1 BSE Sensex 27,850 Nifty 8,633 Reuters Code ITC.BO Bloomberg Code ITC@IN Shareholding Pattern (%) Promoters 0.0 MF / Banks / Indian Fls 38.7 FII / NRIs / OCBs 51.2 Indian Public / Others 10.1 Abs. (%) 3m 1yr 3yr Sensex 0.1 13.8 34.6 ITC 5.8 5.8 18.3 3-year price chart 300 250 200 150 100 50 Source: Company, Angel Research Amarjeet S Maurya 022 3935 7800 Ext: 6831 Amarjeet.maurya@angelbroking.com Please refer to important disclosures at the end of this report 1 0 Jan-14 Apr-14 Jul-14 Oct-14 Jan-15 Apr-15 Jul-15 Oct-15 Jan-16 Apr-16 Jul-16 Oct-16 Jan-17

Exhibit 1: Quarterly performance (Standalone) Y/E March (` cr) 3QFY17 3QFY16 % yoy 2QFY17 %qoq Net Sales 9,248 8,867 4.3 9,661 (4.3) Consumption of RM 3,377 3,028 11.5 3,671 (8.0) (% of Sales) 36.51 34.15 38.0 Staff Costs 572 571 0.2 600 (4.7) (% of Sales) 6.2 6.4 6.2 Other Expenses 1,753 1,793 (2.2) 1,759 (0.3) (% of Sales) 19.0 20.2 18.2 Total Expenditure 5,702 5,392 5.7 6,031 (5.5) Operating Profit 3,546 3,475 2.1 3,630 (2.3) OPM 38.3 39.2 (84) 37.6 77 Interest 14 16 (15.5) 11 26.8 Depreciation & Ammortisation 267 262 1.8 268 (0.7) Other Income 688 649 6.0 475 44.7 PBT (excl. Extraordinary Items) 3,954 3,846 2.8 3,826 3.3 Extraordinary Income/(Expense) - - - PBT (incl. Extraordinary Items) 3,954 3,846 2.8 3,826 3.3 (% of Sales) 42.8 43.4 39.6 Provision for Taxation 1,307 1,342 (2.6) 1,326 (1.4) (% of PBT) 33.1 34.9 34.7 Reported PAT 2,647 2,504 5.7 2,500 5.9 PATM 29 28 26 Source: Company, Angel Research January 30, 2017 2

Top-line remains subdued ITC s net sales for the quarter grew by 4.3% yoy to `9,248cr. In terms of segment wise performance (gross level), the Cigarettes business posted a growth of 2.2% yoy in sales to `8,288cr aided by price hike (volume was flattish during the quarter). The other FMCG businesses posted a growth of 3.4% yoy in sales to `2,569cr. However, the Hotel division and Agri business posted a healthy revenue growth of ~7% and ~13% respectively during the quarter. Operating profit up 2% yoy The company reported an operating profit of `3,546cr during 3QFY2017, up 2% yoy. Further, the company s OPM declined by 84bp yoy to 38.3% owing to an increase in raw material cost. Exhibit 2: Segment-wise performance (Standalone) Y/E Mar (` cr) 3QFY17 3QFY16 % yoy 2QFY17 % qoq Gross Income Cigarettes 8,288 8,106 2.2 8,528 (2.8) Others 2,569 2,485 3.4 2,672 (3.8) Hotels 371 345 7.3 297 24.6 Agri Business 1,672 1,481 12.9 1,880 (11.1) Paperboards & Packaging 1,336 1,338 (0.1) 1,331 0.3 PBIT Cigarettes 3,034 2,984 1.7 3,217 (5.7) Others (20) 19 (204.9) (3) 503.1 Hotels 42 26 63.2 1 6384.6 Agri Business 237 235 0.7 297 (20.3) Paperboards & Packaging 246 241 2.1 232 6.1 PBIT Margin (%) Cigarettes 36.6 36.8 37.7 Others (0.8) 0.8 (0.1) Hotels 11.4 7.5 0.2 Agri Business 14.2 15.9 15.8 Paperboards & Packaging 18.4 18.0 17.4 Source: Company, Angel Research January 30, 2017 3

Investment rationale Cigarettes business to enjoy strong pricing power: We believe ITC s cigarettes business is well poised to continue to record healthy growth over FY2016-18E due to its strong pricing power and improvement in volume. Non-cigarettes businesses to register healthy growth over FY2016-18E: While cigarettes remain the main profit center for the company, investments in the non-cigarettes businesses such as FMCG, Hotels and Paperboards have given the company a foothold in the respective businesses. We expect these businesses to play a major role in driving the company s long-term growth. Outlook and valuation We expect ITC to report a top-line and bottom-line CAGR of 9% and 12% respectively over FY2016-18E. At the current market price, the stock is trading at 26.9x its FY2018E EPS. We recommend an Accumulate rating on the stock with a Target Price of `284. Company Background ITC is a diversified conglomerate, present across various categories Cigarettes (41% of revenue), Hotels (3% of revenue), Paperboards and Packaging (13% of revenue), Agri-business (22% of revenue), and other FMCG businesses (branded apparel, personal care, stationery, safety matches and specialty papers - 21% of revenue). Although ITC is a market leader in the cigarettes category, it is rapidly gaining market share even in its evolving businesses of packaged foods and confectionery, branded apparel, personal care and stationery. January 30, 2017 4

Profit and loss statement (Standalone) Y/E March (` cr) FY13 FY14 FY15 FY16 FY17E FY18E Total operating income 29,901 33,239 36,507 36,583 38,935 43,170 % chg 18.9 11.2 9.8 0.2 6.4 10.9 Total Expenditure 19,274 20,784 23,034 22,865 24,023 26,248 Cost of Materials 12,066 13,156 14,672 13,450 14,328 15,757 Personnel 1,387 1,608 1,780 2,328 2,025 2,288 Others 5,821 6,019 6,582 7,086 7,670 8,202 EBITDA 10,628 12,455 13,474 13,718 14,912 16,923 % chg 20.1 17.2 8.2 1.8 8.7 13.5 (% of Net Sales) 35.5 37.5 36.9 37.5 38.3 39.2 Depreciation& Amortisation 796 900 962 1,032 1,162 1,328 EBIT 9,832 11,555 12,512 12,686 13,750 15,595 % chg 20.6 17.5 8.3 1.4 8.4 13.4 (% of Net Sales) 32.9 34.8 34.3 34.7 35.3 36.1 Interest & other Charges 86 3 57 49 55 60 Other Income 939 1,107 1,543 1,769 1,769 1,769 (% of PBT) 8.8 8.7 11.0 12.3 11.4 10.2 Share in profit of Associates - - - - - - Recurring PBT 10,684 12,659 13,998 14,406 15,464 17,304 % chg 20.1 18.5 10.6 2.9 7.3 11.9 Extraordinary Expense/(Inc.) - - - - - - PBT (reported) 10,684 12,659 13,998 14,406 15,464 17,304 Tax 3,266 3,874 4,390 5,095 5,103 5,710 (% of PBT) 30.6 30.6 31.4 35.4 33.0 33.0 PAT (reported) 7,418 8,785 9,608 9,311 10,361 11,594 Add: Share of associates - - - - - - ADJ. PAT 7,418 8,785 9,608 9,311 10,361 11,594 % chg 20.4 18.4 9.4 (3.1) 11.3 11.9 (% of Net Sales) 24.8 26.4 26.3 25.5 26.6 26.9 Basic EPS (`) 6.1 7.3 8.0 7.7 8.6 9.6 Fully Diluted EPS (`) 6.1 7.3 8.0 7.7 8.6 9.6 % chg 20.4 18.4 9.4 (3.1) 11.3 11.9 January 30, 2017 5

Balance Sheet (Standalone) Y/E March (` cr) FY13 FY14 FY15 FY16 FY17E FY18E SOURCES OF FUNDS Equity Share Capital 790 795 802 805 1,208 1,208 Reserves& Surplus 21,498 25,467 29,934 32,124 37,523 42,856 Shareholders Funds 22,288 26,262 30,736 32,929 38,731 44,064 Minority Interest - - - - - - Total Loans 78 67 53 42 40 40 Deferred Tax Liability 1,706 1,741 2,099 2,370 2,370 2,370 Total Liabilities 24,072 28,070 32,888 35,341 41,141 46,475 APPLICATION OF FUNDS Gross Block 16,944 18,545 21,727 22,648 27,184 30,684 Less: Acc. Depreciation 5,735 6,532 7,548 8,443 9,605 10,933 Net Block 11,209 12,013 14,178 14,205 17,579 19,751 Capital Work-in-Progress 1,488 2,296 2,114 2,501 2,501 2,501 Investments 7,060 8,823 8,405 12,854 12,854 12,854 Current Assets 14,260 16,097 19,498 19,959 21,427 23,647 Inventories 6,600 7,360 7,837 8,520 9,067 10,172 Sundry Debtors 1,163 2,165 1,722 1,686 1,600 1,656 Cash 3,615 3,289 7,589 6,564 7,061 7,502 Loans & Advances 1,154 1,803 843 903 1,168 1,511 Other 1,728 1,480 1,506 2,285 2,531 2,806 Current liabilities 10,448 11,604 11,775 14,699 13,741 12,800 Net Current Assets 3,812 4,494 7,722 5,260 7,686 10,847 Deferred Tax Asset 503 445 468 522 522 522 Mis. Exp. not written off - - - - - - Total Assets 24,072 28,070 32,888 35,341 41,141 46,475 January 30, 2017 6

Cash flow statement (Standalone) Y/E March (` cr) FY13 FY14 FY15 FY16 FY17E FY18E Profit before tax 10,684 12,659 13,998 14,958 15,464 17,304 Depreciation 796 900 962 1,034 1,162 1,328 Change in Working Capital (1,049) (1,732) 30 (162) (1,929) (2,720) Interest / Dividend (Net) (580) (767) (1,131) (1,179) 55 60 Direct taxes paid (2,886) (3,797) (4,226) (4,828) (5,103) (5,710) Others (255) (300) (324) (573) - - Cash Flow from Operations 6,710 6,962 9,309 9,251 9,649 10,262 (Inc.)/ Dec. in Fixed Assets (4,324) (4,586) (4,402) (11,075) (3,500) (3,500) (Inc.)/ Dec. in Investments (744) (1,763) 418 (4,449) - - Cash Flow from Investing (3,581) (2,823) (4,820) (6,626) (3,500) (3,500) Issue of Equity 922 691 979 3 - - Inc./(Dec.) in loans (10) (11) (15) (11) (2) - Dividend Paid (Incl. Tax) (3,518) (4,148) (4,772) (4,935) (5,595) (6,261) Interest / Dividend (Net) 273 (996) 3,619 1,292 (55) (60) Cash Flow from Financing (2,333) (4,465) (190) (3,650) (5,652) (6,321) Inc./(Dec.) in Cash 796 (326) 4,299 (1,025) 497 441 Opening Cash balances 2,819 3,615 3,289 7,589 6,564 7,061 Closing Cash balances 3,615 3,289 7,589 6,564 7,061 7,502 January 30, 2017 7

Key ratios Y/E March FY13 FY14 FY15 FY16 FY17E FY18E Valuation Ratio (x) P/E (on FDEPS) 42.0 35.5 32.4 33.5 30.1 26.9 P/CEPS 37.9 32.2 29.5 30.1 27.0 24.1 P/BV 14.0 11.9 10.2 9.5 8.1 7.1 Dividend yield (%) 2.0 2.3 1.6 1.6 1.8 2.0 EV/Sales 10.1 9.0 8.1 8.0 7.5 6.7 EV/EBITDA 28.3 24.1 21.9 21.3 19.6 17.2 EV / Total Assets 8.7 7.6 6.6 5.8 5.3 4.9 Per Share Data (`) EPS (Basic) 6.1 7.3 8.0 7.7 8.6 9.6 EPS (fully diluted) 6.1 7.3 8.0 7.7 8.6 9.6 Cash EPS 6.8 8.0 8.7 8.6 9.5 10.7 DPS 5.3 6.0 4.1 4.1 4.6 5.2 Book Value 18.4 21.7 25.4 27.2 32.0 36.4 Returns (%) RoCE 44.0 43.9 40.6 38.5 35.5 35.4 Angel RoIC (Pre-tax) 84.1 81.3 84.6 93.6 72.9 65.7 RoE 33.3 33.5 31.3 28.3 26.8 26.3 Turnover ratios (x) Asset Turnover 1.8 1.8 1.7 1.6 1.4 1.4 Inventory / Sales (days) 81 81 78 85 85 86 Receivables (days) 14 24 17 17 15 14 Payables (days) 24 25 22 25 26 26 Net Working capital (days) 71 79 74 77 74 74 January 30, 2017 8

Research Team Tel: 022-39357800 E-mail: research@angelbroking.com Website: www.angelbroking.com DISCLAIMER Angel Broking Private Limited (hereinafter referred to as Angel ) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited and Metropolitan Stock Exchange Limited. It is also registered as a Depository Participant with CDSL and Portfolio Manager with SEBI. It also has registration with AMFI as a Mutual Fund Distributor. Angel Broking Private Limited is a registered entity with SEBI for Research Analyst in terms of SEBI (Research Analyst) Regulations, 2014 vide registration number INH000000164. Angel or its associates has not been debarred/ suspended by SEBI or any other regulatory authority for accessing /dealing in securities Market. Angel or its associates/analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and risks of such an investment. Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamentals. Investors are advised to refer the Fundamental and Technical Research Reports available on our website to evaluate the contrary view, if any. The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for general guidance only. Angel Broking Pvt. Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Angel Broking Pvt. Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking Pvt. Limited endeavors to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced, redistributed or passed on, directly or indirectly. Neither Angel Broking Pvt. Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in connection with the use of this information. Disclosure of Interest Statement ITC 1. Financial interest of research analyst or Angel or his Associate or his relative No 2. Ownership of 1% or more of the stock by research analyst or Angel or associates or relatives No 3. Served as an officer, director or employee of the company covered under Research No 4. Broking relationship with company covered under Research No Ratings (Based on expected returns Buy (> 15%) Accumulate (5% to 15%) Neutral (-5 to 5%) over 12 months investment period): Reduce (-5% to -15%) Sell (< -15) January 30, 2017 9